熊本大学大学院医学薬学研究部(医学系)生体機能薬理学分野


 
熊本大学

熊本大学大学院医学薬学研究部



トップページ > 研究業績 > 英文原著 > 2003年   
研究業績(英文原著)
| 2000年 | 2001年 | 2002年 | 2003年 : 和文総説 : 著書 | 2004年 | 2005年 | 2006年 | 2007年

 
(2003年)

Kim S and Iwao H. Stress and vascular responses:
mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling.
J Pharmacol Sci vol.91:177-181. 2003

Kawano H, Kim S, Ohta K, Nakao T, Miyazaki H, Nakatani T, Iwao H.
Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression.
J Am Soc Nephrol vol.14:584-592. 2003

Takai S, Jin D, Sakaguchi M, Katayama S, Muramatsu M, Matsumura E, Kim S, Miyazaki M.
A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-a zetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
J Pharmacol Exp Ther vol.305:17-23. 2003

Takai S, Kim S, Sakonjo H, Miyazaki M.
Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet.
J Hypertens vol.21:361-369. 2003

Tamada S, Nakatani T, Asai T, Tashiro K, Komiya T, Sumi T, Okamura M, Kim S, Iwao H, Kishimoto T, Yamanaka S, Miura K.
Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy.
Kidney Int vol.63:306-314. 2003

Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Cardiovasc Res vol.57:48-54. 2003

Ioroi T, Yamamori M, Yagi K, Hirai M, Zhan Y, Kim S, Iwao H.
Dominant negative c-Jun inhibits platelet-derived growth factor-directed migration by vascular smooth muscle cells.
J Pharmacol Sci vol.91:145-148. 2003

Asai T, Nakatani T, Tamada S, Kuwabara N, Yamanaka S, Tashiro K, Nakao T, Komiya T, Okamura M, Kim S, Iwao H, Miura K.
Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation.
Transplantation vol.75:1040-1044. 2003

Bamba S, Andoh A, Yasui H, Makino J, Kim S, Fujiyama Y.
Regulation of interleukin-11 expression in human intestinal myofibroblasts: role of c-Jun AP-1- and MAP-kinase-dependent pathways.
Am J Physiol (Gastrointest Liver Physiol) G529-G538. 2003

Izumiya Y, Kim S, Izumi Y, Yoshida K, Yoshiyama M, Matsuzawa A, Ichijo H, Iwao H.
Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Circ Res. vol.93:874-883. 2003

Izumi Y, Kim S, Yoshiyama M, Izumiya Y, Yoshida K, Matsuzawa A, Koyama H, Nishizawa Y, Ichijo H, Yoshikawa J, Iwao H.
Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
Circulation. vol.108:2812-2818. 2003

Yamada M, Kim S, Egashira K, Takeya M, Ikeda T, Mimura O, Iwao H.
Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
Arterioscler Thromb Vasc Biol. vol.23:1996-2001. 2003

 
2002年英文原著  2002年英文原著
2004年英文原著  2004年英文原著

 
このページのトップへ このページのトップへ